In a filing, Cytokinetics Inc revealed its EVP, Chief Commercial Officer Callos Andrew unloaded Company’s shares for reported $0.1 million on Apr 07 ’25. In the deal valued at $35.78 per share,2,886 shares were sold. As a result of this transaction, Callos Andrew now holds 64,689 shares worth roughly $2.33 million.
Then, ANDREW CALLOS bought 15,547 shares, generating $580,836 in total proceeds.
Before that, Harrington Robert Arthur sold 450 shares. Cytokinetics Inc shares valued at $17,744 were divested by the Director at a price of $39.43 per share. As a result of the transaction, Harrington Robert Arthur now holds 14,658 shares, worth roughly $0.53 million.
Citigroup initiated its Cytokinetics Inc [CYTK] rating to a Buy in a research note published on February 07, 2025; the price target was $86. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in late January with a ‘”a Buy”‘ rating. RBC Capital Mkts began covering CYTK with “an Outperform” recommendation on November 08, 2024. Goldman revised its rating on August 13, 2024. It rated CYTK as “a Neutral” which previously was an “a Buy”.
Price Performance Review of CYTK
On Monday, Cytokinetics Inc [NASDAQ:CYTK] saw its stock fall -3.67% to $35.99. Over the last five days, the stock has lost -10.45%. Cytokinetics Inc shares have fallen nearly -23.49% since the year began. Nevertheless, the stocks have fallen -47.98% over the past one year. While a 52-week high of $75.71 was reached on 01/27/25, a 52-week low of $36.89 was recorded on 04/07/25. SMA at 50 days reached $44.73, while 200 days put it at $51.06.
Levels Of Support And Resistance For CYTK Stock
The 24-hour chart illustrates a support level at 34.09, which if violated will result in even more drops to 32.19. On the upside, there is a resistance level at 37.99. A further resistance level may holdings at 39.98. The Relative Strength Index (RSI) on the 14-day chart is 32.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.81, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.33%. Stochastics %K at 14.88% indicates the stock is a buying.
How much short interest is there in Cytokinetics Inc?
A steep rise in short interest was recorded in Cytokinetics Inc stocks on 2025-03-14, dropping by -0.85 million shares to a total of 14.22 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 15.07 million shares. There was a decline of -5.97%, which implies that there is a negative sentiment for the stock.
